A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer.
about
Gaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of LifeFROGG high-risk prostate cancer workshop: patterns of practice and literature review. Part II post-radical prostatectomyAdjuvant and salvage radiotherapy after prostatectomy: a systematic review and meta-analysis.Long-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy.Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapyGenomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?Radiotherapy following radical prostatectomy.Radiotherapy in the management of prostate cancer after radical prostatectomy.Long-term complications in men who have early or late radiotherapy after radical prostatectomy.Adjuvant versus salvage radiotherapy following radical prostatectomy: do the AUA/ASTRO guidelines have all the answers?Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.Predictors and rate of adjuvant radiation therapy following radical prostatectomy: A report from the Prostate Cancer Registry.Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?Perineural Invasion and Risk of Lethal Prostate Cancer.Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer.Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer CenterSalvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: clinical outcomes.Radiotherapy after radical prostatectomy: immediate or early delayed?Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.Improving postoperative radiotherapy following radical prostatectomy.[Radiation with additional antiandrogen therapy in recurrent prostate cancer].Contemporary role of postoperative radiotherapy for prostate cancer
P2860
Q26751574-359787C6-AFDC-4660-9B8D-CC420E4CC6EAQ26827690-8CC35268-8A99-4D57-BA5D-903BB4DC9DE0Q28541950-B7FF0916-6071-49D5-AD99-6E4BD5D4DA1BQ34325482-7572B5E0-674A-4E7A-A8FB-BD89461C46E0Q35924258-223AF09A-9D73-4266-9299-67DDFBE031FFQ36945088-9F006EEA-4C8A-4F8A-8E05-5B1C8D2174D5Q37140357-051853B7-F325-4E00-9E8D-9F10CD880A8BQ38030597-B30B90A8-97D7-44BB-AFBF-2472FB38DAABQ38104412-604882C2-5A8E-4EDF-8F79-7004C29F7BD9Q38248286-B4DAA99B-49D6-4F8B-BFC0-EC86FB4DC6ACQ38264782-DDF06AD3-4496-409B-869A-683EB6C32BF1Q38620741-184396B3-2CF1-4E5E-A1FF-40D2FBB24DB6Q38628225-D2B83995-61D6-4E93-9212-E1F6C16C6C68Q38877792-2A4D0C27-7323-4825-BE3E-C73F949A86FEQ39035046-8151EF70-0F18-4025-A291-CC11C7F46C56Q39356227-DA36BAAC-172A-47FD-B0F1-EC96BCE18F0AQ42539752-17A85FB2-473B-4857-BD3F-6D17E1A65306Q44220551-FC5FE0BE-0246-4E3D-9ADA-3182C7FE2A59Q44905750-F62FA861-B6AF-4DD9-BD99-9E58C862FAB8Q46062252-3943D91C-997C-4E47-8404-3EC176F91992Q47645461-9B6D0D9C-0E25-4154-8733-5942C69D6D7BQ47978964-FB9BB2A2-9966-4D57-A80D-41DB85A1E012Q54130488-09849A05-F98E-4B91-A2F0-0FD75B69ACF1Q57112410-791343BB-5F95-4F6A-A068-227EDDB4CE4A
P2860
A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
A matched control analysis of ...... iotherapy for prostate cancer.
@en
A matched control analysis of ...... iotherapy for prostate cancer.
@nl
type
label
A matched control analysis of ...... iotherapy for prostate cancer.
@en
A matched control analysis of ...... iotherapy for prostate cancer.
@nl
prefLabel
A matched control analysis of ...... iotherapy for prostate cancer.
@en
A matched control analysis of ...... iotherapy for prostate cancer.
@nl
P2093
P1476
A matched control analysis of ...... iotherapy for prostate cancer.
@en
P2093
Bart De Troyer
Gert De Meerleer
Valérie Fonteyne
Willem Oosterlinck
P304
P356
10.1016/J.IJROBP.2010.04.039
P407
P577
2010-08-01T00:00:00Z